A perspective on why platform processes are not and should not define the future of bioprocess development efforts. This article is part of a special section on biopharmaceutical trends.
Pratik Jaluria
Advertisement
Articles by Pratik Jaluria
Advertisement
Latest Updated Articles
- Bucking the Trend
September 1st 2012
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
2
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
3
Wave Reports 1-Year INLIGHT Data for INHBE siRNA WVE-007 in Obesity
4
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
5